Skip to main content
. 2021 Jul 6;125(6):854–864. doi: 10.1038/s41416-021-01464-0

Fig. 2. Somatic mutations identified in (n = 6) samples from each patient.

Fig. 2

a Somatic mutations in patients whose TATs shared at least one mutation with primary tumours. b Somatic mutations in patients whose TATs harboured no or private mutations to primary tumours. TAT tumour-adjacent tissue, pre-sctDNA pre-operative SctDNA, pre-ctDNA pre-operative ctDNA, post-sctDNA post-operative SctDNA, post-ctDNA post-operative ctDNA. Patients with a premalignant lesion diagnosed pathologically in TATs are labelled with star icons, while relapsed patients are labelled with hexagon icons. Tumour sites and TNM disease stages were labelled next to patients’ ID. Mutation types are labelled with different colours listed at the bottom right; TAT was not available in P25.